Αρχειοθήκη ιστολογίου

Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174

Πέμπτη 19 Ιουλίου 2018

Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study

Abstract

Background

Hypotension after induction of general anesthesia (GAIH) is common in anesthesiology practice and can impact outcomes.

Methods

In this prospective multicenter, cross-sectional, observational study, the hypotension was defined as a decrease in mean arterial pressure of > 30% compared to the first measurement in the operation theatre before general anesthesia (GA) induction. Blood pressure was measured immediately at the time of endotracheal intubation (TETI), at five (T5) and 10 (T10) minutes after. All subjects aged > 18 years undergoing elective non-cardiac surgery under GA were included. The goals were description of GAIH occurrence, the association of GAIH with selected comorbidities, chronic medications, and anesthetics with GAIH, and the type and efficacy of interventions used to correct hypotension.

Results

Data from 661 subjects, whose GA was induced with propofol and sufentanil, were analyzed. In 36.5% of subjects, GAIH was observed at ≥ 1 of the assessed time points. GAIH was present in 2.9% subjects at all time points. The probability of GAIH is raising with age, degree of hypertension at time of arrival to theatre and presence of diabetes. The type of volatile anesthetic was not associated with the occurrence of GAIH. The overall efficiency of interventions to correct hypotension was 94.4%. Bolus fluids were the most often used intervention and was 96.4% effective.

Conclusion

GAIH rate depends on age, degree of blood pressure decompensation prior the surgery, and presence of diabetes mellitus type II.



https://ift.tt/2uNfVHs

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Conditions:   Head and Neck Carcinoma;   Adenocarcinoma;   Recurrent Disease;   Distantly Metastatic Malignant Neoplasm
Intervention:   Drug: Anlotinib
Sponsor:   Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not yet recruiting

https://ift.tt/2JyDeKs

Effectiveness of Manual Therapy vs Exercises With Foam Rolling for Tension Headache

Condition:   Tension-type Headache
Interventions:   Other: Manual Therapy protocol;   Other: Foam Rolling protocol;   Other: Placebo control
Sponsor:   University of Valencia
Recruiting

https://ift.tt/2Lk3dKr

Editorial Board

Publication date: August 2018

Source: Autoimmunity Reviews, Volume 17, Issue 8

Author(s):



https://ift.tt/2msDJMY

Who Originally Described Pindborg Tumor?



https://ift.tt/2JBSwxR

Consistent LEF-1 and MYB Immunohistochemical Expression in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma: A Potential Diagnostic Pitfall

Abstract

Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC) is a distinct, newly-described sinonasal tract neoplasm characterized by a salivary gland tumor-like appearance with myoepithelial and ductal cells, frequent surface squamous dysplasia, and relatively indolent behavior. When considering a diagnosis of HMSC, aggressive high-grade salivary gland carcinomas, particularly those with a basaloid morphology such as basal cell adenocarcinoma and adenoid cystic carcinoma, enter the differential diagnosis. The full morphologic and immunophenotypic profile of HMSC continues to be unraveled. In this series of ten cases, we demonstrate that this tumor has consistent, strong immunohistochemical expression of LEF-1 yet lacks nuclear expression of β-catenin, and also has consistent yet variable expression of MYB protein. While LEF-1 expression may be a useful diagnostic adjunct, it can also be a pitfall, as other salivary tumors such as basal cell adenocarcinoma have been previously shown to express LEF-1. Additionally, MYB protein expression is not a discriminatory marker when trying to separate HMSC from adenoid cystic carcinoma.



https://ift.tt/2LlOOxy

Who Originally Described Pindborg Tumor?



https://ift.tt/2JBSwxR